• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病相关的 LRRK2 与自身磷酸化相比,在体外对 4E-BP 的磷酸化作用较弱。

The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation.

机构信息

Cell Biology and Gene Expression Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, United States of America.

出版信息

PLoS One. 2010 Jan 15;5(1):e8730. doi: 10.1371/journal.pone.0008730.

DOI:10.1371/journal.pone.0008730
PMID:20090955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2806920/
Abstract

Mutations in the gene encoding Leucine-rich repeat kinase 2 (LRRK2) are the most common cause of inherited Parkinson's disease (PD). LRRK2 is a multi-domain protein kinase containing a central catalytic core and a number of protein-protein interaction domains. An important step forward in the understanding of both the biology and the pathology of LRRK2 would be achieved by identification of its authentic physiological substrates. In the present study we examined phosphorylation of 4E-BP (eukaryotic initiation factor 4E (eIF4E)-binding protein), a recently proposed substrate for LRRKs. We found that LRRK2 is capable of phosphorylating 4E-BP in vitro. The PD related LRRK2-G2019S mutant was approximately 2 fold more active than wild type protein. However, LRRK2 autophosphorylation was stronger than 4E-BP phosphorylation under conditions of molar excess of 4E-BP to LRRK2. We also tested three other kinases (STK3, MAPK14/p38alpha and DAPK2) and found that MAPK14/p38alpha could efficiently phosphorylate 4E-BP at the same site as LRRK2 in vitro. Finally, we did not see changes in 4E-BP phosphorylation levels using inducible expression of LRRK2 in HEK cell lines. We also found that MAPK14/p38alpha phosphorylates 4E-BP in transient overexpression experiments whereas LRRK2 did not. We suggest that increased 4E-BP phosphorylation reported in some systems may be related to p38-mediated cell stress rather than direct LRRK2 activity. Overall, our results suggest that 4E-BP is a relatively poor direct substrate for LRRK2.

摘要

LRRK2 基因编码的突变是遗传性帕金森病 (PD) 的最常见原因。LRRK2 是一种含有中央催化核心和多个蛋白-蛋白相互作用结构域的多结构域蛋白激酶。鉴定其真实的生理底物,将是在理解 LRRK2 的生物学和病理学方面的重要进展。在本研究中,我们检测了 4E-BP(真核起始因子 4E (eIF4E)-结合蛋白)的磷酸化,这是最近提出的 LRRK2 的底物。我们发现 LRRK2 能够在体外磷酸化 4E-BP。与野生型蛋白相比,PD 相关的 LRRK2-G2019S 突变体的活性约增加了 2 倍。然而,在 4E-BP 与 LRRK2 的摩尔比过量的情况下,LRRK2 的自身磷酸化比 4E-BP 的磷酸化要强。我们还测试了另外三种激酶 (STK3、MAPK14/p38alpha 和 DAPK2),并发现 MAPK14/p38alpha 可以在体外有效地在与 LRRK2 相同的位点磷酸化 4E-BP。最后,我们在 HEK 细胞系中用诱导表达 LRRK2 的方法,没有观察到 4E-BP 磷酸化水平的变化。我们还发现,在瞬时过表达实验中,MAPK14/p38alpha 磷酸化 4E-BP,而 LRRK2 则没有。我们认为,一些系统中报道的 4E-BP 磷酸化增加可能与 p38 介导的细胞应激有关,而不是直接与 LRRK2 的活性有关。总的来说,我们的结果表明 4E-BP 是 LRRK2 的相对较差的直接底物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/3b60627d74ef/pone.0008730.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/37277b5fb67f/pone.0008730.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/ad3e194ecb3c/pone.0008730.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/d8cda377ad16/pone.0008730.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/89e23894289e/pone.0008730.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/3b60627d74ef/pone.0008730.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/37277b5fb67f/pone.0008730.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/ad3e194ecb3c/pone.0008730.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/d8cda377ad16/pone.0008730.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/89e23894289e/pone.0008730.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a8/2806920/3b60627d74ef/pone.0008730.g005.jpg

相似文献

1
The Parkinson's disease associated LRRK2 exhibits weaker in vitro phosphorylation of 4E-BP compared to autophosphorylation.帕金森病相关的 LRRK2 与自身磷酸化相比,在体外对 4E-BP 的磷酸化作用较弱。
PLoS One. 2010 Jan 15;5(1):e8730. doi: 10.1371/journal.pone.0008730.
2
Phosphorylation of 4E-BP1 in the mammalian brain is not altered by LRRK2 expression or pathogenic mutations.哺乳动物大脑中 4E-BP1 的磷酸化不受 LRRK2 表达或致病突变的影响。
PLoS One. 2012;7(10):e47784. doi: 10.1371/journal.pone.0047784. Epub 2012 Oct 17.
3
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.LRRK2对4E-BP的磷酸化作用影响果蝇中多巴胺能神经元的维持。
EMBO J. 2008 Sep 17;27(18):2432-43. doi: 10.1038/emboj.2008.163. Epub 2008 Aug 14.
4
Association between LRRK2 and 4E-BP1 protein levels in normal and malignant cells.LRRK2 与正常和恶性细胞中 4E-BP1 蛋白水平的关联。
Oncol Rep. 2012 Jan;27(1):225-31. doi: 10.3892/or.2011.1462. Epub 2011 Sep 14.
5
Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease.诱导型富亮氨酸重复激酶 2(LRRK2)细胞系的开发用于帕金森病的治疗药物研发。
Neurotherapeutics. 2013 Oct;10(4):840-51. doi: 10.1007/s13311-013-0208-3.
6
Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways.LRRK2 Roc-COR 串联结构域突变将帕金森病与 Wnt 信号通路联系起来。
Hum Mol Genet. 2009 Oct 15;18(20):3955-68. doi: 10.1093/hmg/ddp337. Epub 2009 Jul 22.
7
Leucine-rich repeat kinase 2 modulates retinoic acid-induced neuronal differentiation of murine embryonic stem cells.富含亮氨酸重复激酶 2 调节维甲酸诱导的鼠胚胎干细胞的神经元分化。
PLoS One. 2011;6(6):e20820. doi: 10.1371/journal.pone.0020820. Epub 2011 Jun 9.
8
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.与帕金森病相关的蛋白激酶LRRK2在体外表现出丝裂原活化蛋白激酶激酶激酶(MAPKKK)活性,并使MKK3/6和MKK4/7磷酸化。
J Neurochem. 2009 May;109(4):959-68. doi: 10.1111/j.1471-4159.2009.06024.x. Epub 2009 Mar 3.
9
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications.富含亮氨酸重复激酶2(Lrrk2)使α-突触核蛋白在丝氨酸129位点磷酸化:对帕金森病的影响
Biochem Biophys Res Commun. 2009 Sep 11;387(1):149-52. doi: 10.1016/j.bbrc.2009.06.142. Epub 2009 Jul 1.
10
The synaptic function of LRRK2.LRRK2 的突触功能。
Biochem Soc Trans. 2012 Oct;40(5):1047-51. doi: 10.1042/BST20120113.

引用本文的文献

1
Identification of necroptosis-related genes in Parkinson's disease by integrated bioinformatics analysis and experimental validation.通过综合生物信息学分析和实验验证鉴定帕金森病中与坏死性凋亡相关的基因
Front Neurosci. 2023 May 22;17:1097293. doi: 10.3389/fnins.2023.1097293. eCollection 2023.
2
Local Translation in Nervous System Pathologies.神经系统疾病中的局部翻译
Front Integr Neurosci. 2021 Jun 29;15:689208. doi: 10.3389/fnint.2021.689208. eCollection 2021.
3
Pathogenic LRRK2 requires secondary factors to induce cellular toxicity.

本文引用的文献

1
Identification of the autophosphorylation sites of LRRK2.亮氨酸丰富重复激酶2(LRRK2)自磷酸化位点的鉴定
Biochemistry. 2009 Nov 24;48(46):10963-75. doi: 10.1021/bi9011379.
2
The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites.帕金森病激酶LRRK2在多个位点使其GTPase结构域发生自磷酸化。
Biochem Biophys Res Commun. 2009 Nov 20;389(3):449-54. doi: 10.1016/j.bbrc.2009.08.163. Epub 2009 Sep 3.
3
Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss.雷帕霉素对4E-BP的激活可预防帕金森病多巴胺能神经元的损失。
致病性 LRRK2 需要辅助因子诱导细胞毒性。
Biosci Rep. 2020 Oct 30;40(10). doi: 10.1042/BSR20202225.
4
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same.LRRK2 生物学:从结构到功能障碍:研究进展,但主题不变。
Mol Neurodegener. 2019 Dec 21;14(1):49. doi: 10.1186/s13024-019-0344-2.
5
Genetic Modifiers of Neurodegeneration in a Model of Parkinson's Disease.帕金森病模型中神经退行性变的遗传修饰物。
Genetics. 2018 Aug;209(4):1345-1356. doi: 10.1534/genetics.118.301119. Epub 2018 Jun 15.
6
The LRRK2 signalling system.LRRK2 信号系统。
Cell Tissue Res. 2018 Jul;373(1):39-50. doi: 10.1007/s00441-017-2759-9. Epub 2018 Jan 8.
7
The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration.果蝇hep通路介导Lrrk2诱导的神经退行性变。
Biochem Cell Biol. 2018 Aug;96(4):441-449. doi: 10.1139/bcb-2017-0262. Epub 2017 Dec 21.
8
LRRK2 regulates retrograde synaptic compensation at the Drosophila neuromuscular junction.LRRK2 调控果蝇神经肌肉接点的逆行性突触补偿。
Nat Commun. 2016 Jul 19;7:12188. doi: 10.1038/ncomms12188.
9
Decoding Parkinson's Disease Pathogenesis: The Role of Deregulated mRNA Translation.解码帕金森病发病机制:失调的mRNA翻译的作用
J Parkinsons Dis. 2016;6(1):17-27. doi: 10.3233/JPD-150738.
10
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases.磷酸化蛋白质组学研究表明,帕金森病激酶LRRK2调节Rab GTP酶的一个亚群。
Elife. 2016 Jan 29;5:e12813. doi: 10.7554/eLife.12813.
Nat Neurosci. 2009 Sep;12(9):1129-35. doi: 10.1038/nn.2372. Epub 2009 Aug 16.
4
Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.富含亮氨酸重复激酶 2 突变与帕金森病:三个问题。
ASN Neuro. 2009 Apr 14;1(1):e00002. doi: 10.1042/AN20090007.
5
Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability--a point of convergence in parkinsonian neurodegeneration?富含亮氨酸重复序列激酶2使脑微管蛋白β亚型磷酸化并调节微管稳定性——这是帕金森病神经退行性变的一个交汇点?
J Neurochem. 2009 Sep;110(5):1514-22. doi: 10.1111/j.1471-4159.2009.06235.x. Epub 2009 Jun 22.
6
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro.与帕金森病相关的蛋白激酶LRRK2在体外表现出丝裂原活化蛋白激酶激酶激酶(MAPKKK)活性,并使MKK3/6和MKK4/7磷酸化。
J Neurochem. 2009 May;109(4):959-68. doi: 10.1111/j.1471-4159.2009.06024.x. Epub 2009 Mar 3.
7
Investigation of leucine-rich repeat kinase 2 : enzymological properties and novel assays.富含亮氨酸重复激酶2的研究:酶学性质与新型检测方法
FEBS J. 2009 Jan;276(2):466-78. doi: 10.1111/j.1742-4658.2008.06789.x.
8
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.LRRK2对4E-BP的磷酸化作用影响果蝇中多巴胺能神经元的维持。
EMBO J. 2008 Sep 17;27(18):2432-43. doi: 10.1038/emboj.2008.163. Epub 2008 Aug 14.
9
Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation.帕金森病相关G2019S LRRK2突变主导模式的机制洞察。
Hum Mol Genet. 2007 Sep 1;16(17):2031-9. doi: 10.1093/hmg/ddm151. Epub 2007 Jun 20.
10
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.富含亮氨酸重复激酶2(LRRK2)使埃兹蛋白(moesin)的苏氨酸-558位点发生磷酸化:帕金森病突变体对激酶活性影响的特征分析
Biochem J. 2007 Jul 15;405(2):307-17. doi: 10.1042/BJ20070209.